-+ 0.00%
-+ 0.00%
-+ 0.00%

Viatris Inc. Announces Positive Results from Phase 3 Trials of MR-142 and MR-141, and Provides Update on MR-139 Study for Blepharitis

Reuters·07/18/2025 10:59:21

Please log in to view news